Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway.

Saved in:
Bibliographic Details
Title: Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway.
Authors: Zoheir KMA; Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Abd-Rabou AA; Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt., Darwish AM; Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Abdelhafez MA; Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Mahrous KF; Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
Source: Frontiers in oncology [Front Oncol] 2022 Oct 05; Vol. 12, pp. 998247. Date of Electronic Publication: 2022 Oct 05 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.998247